Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Other Nonoperating Expense

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Other Nonoperating Expense

Definium Therapeutics, Inc. (DFTX) reported Other Nonoperating Expense of $51.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-06.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingExpense · last filed 2025-03-06

  • Definium Therapeutics, Inc. other nonoperating expense for the quarter ending 2023-12-31 was $0.00.
  • Definium Therapeutics, Inc. other nonoperating expense for the quarter ending 2023-09-30 was $51.00K.
  • Definium Therapeutics, Inc. other nonoperating expense for fiscal 2023 was $51.00K.
Period endOther Nonoperating Expense 3 monthOther Nonoperating Expense 6 monthOther Nonoperating Expense 9 monthOther Nonoperating Expense 12 month
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$51.00K
derived: sum of 2 quarters · filed 2025-03-06
$51.00K
10-K · filed 2025-03-06
2023-09-30$51.00K
10-Q · filed 2024-11-07
$51.00K
10-Q · filed 2024-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B